Linear accelerator is island's first Versa HD PONCE, Puerto Rico, May 17, 2013 -- (Healthcare Sales & Marketing Network) -- Serving a region of 650,000 inhabitants in southern, central and western Puerto Rico, Caribbean Imaging and Radiation Therapy (C...
Devices, Oncology
Elekta, Versa HD, stereotactic, radiosurgery, radiotherapy

PLEASANTON, Calif., May 17, 2013 -- (Healthcare Sales & Marketing Network) -- Thoratec Corporation (THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it has rec...
Devices, Cardiology, FDA
Thoratec, HeartMate II, Pocket Controller, HeartMate II LVAD

Genentech and Biogen Idec have filed for re-hearing in the United States COPENHAGEN, Denmark, May 17, 2013 -- (Healthcare Sales & Marketing Network) -- Genmab A/S (GEN.CO) announced today that Genentech and Biogen Idec have filed for a re-hearing en ba...
Biopharmaceuticals, Litigation
Genmab, Genentech, Biogen Idec, GlaxoSmithKline, Arzerra

NATICK, Mass., May 17, 2013 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (BSX) is scheduled to participate at the annual EuroPCR Scientific Program May 21-24 in Paris. "We are pleased to present a particularly rich an...
Devices, Interventional Cardiology
Boston Scientific, NG PROMUS trial, Promus PREMIER, SYNERGY Stent

Data Showed Reduced Nocturnal Systolic Blood Pressure Elevations and Periodic Limb Movements During Sleep in Restless Legs Syndrome (RLS) Patients First study of its kind will be presented at the Annual Scientific Meeting of the American Society of Hype...
Biopharmaceuticals
UCB , Neupro, Rotigotine, Restless Legs Syndrome

More than 18 Million Brazilians have Reimbursable Access to MGuard EPS BOSTON and TEL AVIV, Israel, May 16, 2013 -- (Healthcare Sales & Marketing Network) --InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader i...
Devices, Interventional, Cardiology, Reimbursement
InspireMD, MGuard, Embolic Protection, Coronary Stent

To Begin I-124-CLR1404 (LIGHT) Phase 2 Imaging Trial in Brain Cancer in Early 2014 Evaluating I-131-CLR1404 (HOT) Potential Phase 2 Indications and Trial Designs To File CLR1502 (GLOW2) IND for Intraoperative Tumor Margin Illumination by End 2013 MADI...
Biopharmaceuticals
Novelos Therapeutics, I-124-CLR1404, I-131-CLR1404, radiotherapeutic

Up To 30 European Sites To Join 46 Active Sites In The US BETHESDA, Md., May 16, 2013 -- (Healthcare Sales & Marketing Network) -- Northwest Biotherapeutics (NWBO) (NW Bio), a biotechnology company developing DCVax®-L personalized immune therapies ...
Biopharmaceuticals, Oncology
Northwest Biotherapeutics, DCVax-L, personalized immune therapies, Glioblastoma

Next-generation system provides a real-time 360-degree panoramic view of the arteries in 3-D ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)--St. Jude Medical, Inc. (STJ), a global medical device company, today announced CE Mark approval of its ...
Devices, Interventional Cardiology, Regulatory
St. Jude Medical, ILUMIEN OPTIS, PCI Optimization System, FFR

Published in the June 2013 Issue of Anesthesia & Analgesia, Study Demonstrates that Acoustic Respiration Rate (RRa™) is More Sensitive to Ventilation Changes than Capnometry IRVINE, Calif., May 16, 2013 -- (Healthcare Sales & Marketing Network) -- Masi...
Devices, Monitoring
Masimo, Acoustic Respiration Rate, RRa, rainbow Acoustic Monitoring

BROOMFIELD, CO, May 16, 2013 -- (Healthcare Sales & Marketing Network) -- Colibri Heart Valve, LLC, a privately held medical device company, today announced that Dr. Pedro Urenya will present six month follow-up results from the first-in-human implantation...
Devices, Interventional Cardiology
Colibri Heart Valve, transcatheter aortic heart valve, TAVI system

Demonstration coincides with Symphony's upcoming CE Mark pivotal trial PHILADELPHIA, May 16, 2013 -- (Healthcare Sales & Marketing Network) -- Echo Therapeutics, Inc. (ECTE), a company developing its needle-free Symphony® CGM System as a non-invasi...
Devices, Endocrinology, Monitoring
Echo Therapeutics, Symphony CGM, continuous glucose monitor

Interim Phase II Data and Follow-Up Analysis of Phase I Data Presented at Annual Meeting of the American Society of Gene and Cell Therapy DALLAS, May 15, 2013 -- (Healthcare Sales & Marketing Network) -- Today Gradalis, Inc. announced that FANG™, the c...
Biopharmaceuticals, Personalized Medicine, Oncology
Gradalis, FANG, personalized cancer vaccine, cancer vaccine

The first and only hardware and software upgrade available for Siemens ECAT 47, ECAT HR+, and ECAT Accel PET systems HOUSTON, May 15, 2013--(Healthcare Sales & Marketing Network)--Medical Imaging Electronics (MiE) and Nuclear Imaging Services (NIS) are ...
Devices, Radiology, Oncology, FDA
Medical Imaging Electronics, ECAT Scintron, positron emission tomography

Financing Reflects Encouraging Clinical Progress with Galeterone in Prostate Cancer CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate canc...
Biopharmaceuticals, Oncology, Venture Capital
Tokai Pharmaceuticals, prostate cancer, galeterone, ARMOR2, CRPC

NEW HAVEN, Conn., May 15, 2013 -- (Healthcare Sales & Marketing Network) -- Achillion Pharmaceuticals, Inc. (ACHN) today announced the appointment of David Apelian, M.D., Ph.D., MBA, to the position of Executive Vice President and Chief Medical Officer, ef...
Biopharmaceuticals, Personnel
Achillion Pharmaceuticals

STOCKHOLM--(Healthcare Sales & Marketing Network)--In March RaySearch Laboratories AB announced that version 3.5 of RaySearch's RayStation® treatment planning system had been released for clinical use. RaySearch has now received 510(k) clearance from t...
Devices, Oncology, FDA
RaySearch Laboratories, RayStation, treatment planning, radiotherapy

WAYNE, N.J., May 15, 2013 -- (Healthcare Sales & Marketing Network) -- Bayer HealthCare announced today that patient enrollment is underway for RESORCE (Regorafenib after Sorafenib in Patients with Hepatocellular Carcinoma), an international Phase III tri...
Biopharmaceuticals, Oncology
Bayer HealthCare Pharmaceuticals, Stivarga, regorafenib, liver cancer

Comprehensive SARIL-RA development program to include 2,600 patients in four Phase 3 and one open-label extension trials PARIS and TARRYTOWN, N.Y., May 15, 2013 -- (Healthcare Sales & Marketing Network) -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regen...
Biopharmaceuticals
Regeneron Pharmaceuticals, Sanofi, sarilumab, SARIL-RA, rheumatoid arthritis

FREMONT, Calif., May 14, 2013 -- (Healthcare Sales & Marketing Network) -- Zosano Pharma, Inc., a privately held pharmaceutical company developing products based on its novel transdermal delivery technology, announced today a key addition to its executive...
Biopharmaceuticals, Drug Delivery, Personnel
Zosano Pharma, ZP Patch